Iwasa, Takeshi Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Yanagihara, Rie Tokushima University
Komasaka, Mizuki Tokushima University
Yano, Kiyohito Tokushima University|Shikoku-Central Hospital
Mayila, Yiliyasi Tokushima University
Tachibana, Ayaka Tokushima University
Yamamoto, Yuri Tokushima University Tokushima University Educator and Researcher Directory
Kato, Takeshi Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
low dose FSH
polycystic ovary syndrome
WHO group II
Purpose: To evaluate the optimized protocol of low dose follicle‐stimulating hormone (FSH) therapy that has a starting dose of 50 IU/62.5 IU with a small increment dose (12.5 IU) for women with World Health Organization (WHO) II ovulatory disorder and unexplained infertility.
Methods: Anovulatory women with WHO group II ovulatory disorder (ovulation induction [OI] patients, n = 29), and with an unexplained infertility (ovarian stimulation [OS] patients, n = 21) were enrolled. The protocol of low dose step‐up FSH therapy was optimized for the starting dose as 50 IU (body mass index [BMI] < 20 group) and 62.5 IU (BMI ≥ 20 group) with the increment dose of 12.5 IU. Study outcomes were ovulation, monofollicular development and other variables.
Results: In the OIpatients, the ovulation rate was 100% (BMI < 20 group) and 90.9% (BMI ≥ 20 group). Monofollicular development was 80.0% (BMI < 20) and 77.3% (BMI ≥ 20). The pregnancy rate was 60% (3/5 BMI < 20) and 18.2% (4/22 BMI ≥ 20). There was no multiple pregnancy. In the OSpatients, the ovulation rate was 100%. Monofollicular development was 85.7% (BMI < 20) and 76.6% (BMI ≥ 20). No pregnancy was achieved in the OSpatients.
Conclusion: Optimized protocol of low dose FSH therapy setting a starting dose 50 IU/62.5 IU by BMI with an increment dose of 12.5 IU was safe and highly effective in WHO group II anovulatory patients. However, this protocol seemed uneffective for patients with unexplained infertility.
Reproductive Medicine and Biology
Japan Society for Reproductive Medicine|John Wiley & Sons
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License(https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
|DOI (Published Version)|
|URL ( Publisher's Version )|
rmb_17_3_315.pdf 487 KB